Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia hopes to implement new IVD rules in early 2010

This article was originally published in RAJ Devices

Executive Summary

The redrafting of the Therapeutic Goods (Medical Devices) Regulations 2002 to make provision for the new Australian regulatory framework for in vitro diagnostics is still in progress, but a final draft is expected very soon.

You may also be interested in...



Global medtech alliance approves six new member associations

An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.

Global medtech alliance approves six new member associations

An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.

US FDA scrutiny of DTC genetic tests continues

The US FDA's devices unit has written to three genetic testing companies warning them that they may be marketing their products and services without clearance by the agency.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC095820

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel